Have a feature idea you'd love to see implemented?
Let us know!
GRI GRI Bio Inc
Price (delayed)
$0.808
Market cap
$2.37M
P/E Ratio
0
Dividend/share
N/A
EPS
$457.93
Enterprise value
-$3.85M
Highlights
GRI Bio's EPS has soared by 105% from the previous quarter
The equity has soared by 69% from the previous quarter and by 17% YoY
GRI's quick ratio is up by 18% QoQ but it is down by 4% YoY
Key stats
What are the main financial stats of GRI
Market
Valuations
Earnings
Shares outstanding
2.93M
Market cap
$2.37M
Enterprise value
-$3.85M
Price to earnings (P/E)
0
Price to book (P/B)
0.05
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$8.3M
EBITDA
-$8.33M
Free cash flow
-$11.22M
Per share
Balance sheet
Liquidity
EPS
$457.93
Free cash flow per share
-$24.5
Book value per share
$16.25
Revenue per share
$0
TBVPS
$15.36
Total assets
$7.03M
Total liabilities
$2.31M
Debt
$141,000
Equity
$4.72M
Working capital
$4.67M
Debt to equity
0.03
Current ratio
3.11
Quick ratio
2.87
Net debt/EBITDA
0.75
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-174.5%
Return on equity
-331%
Return on invested capital
N/A
Return on capital employed
-172.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GRI stock price
How has the GRI Bio stock price performed over time
Intraday
-16.7%
1 week
74.1%
1 month
92.2%
1 year
-99.2%
YTD
-97.69%
QTD
123.82%
Financial performance
How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.62M
Net income
-$8.28M
Gross margin
N/A
Net margin
N/A
The net income has grown by 35% from the previous quarter and by 28% YoY
GRI Bio's operating income has increased by 30% from the previous quarter
Growth
What is GRI Bio's growth rate over time
Valuation
What is GRI Bio stock price valuation
P/E
0
P/B
0.05
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has soared by 105% from the previous quarter
The price to book (P/B) is 97% lower than the last 4 quarters average of 2.0
The equity has soared by 69% from the previous quarter and by 17% YoY
Efficiency
How efficient is GRI Bio business performance
GRI's ROE has soared by 58% YoY and by 40% QoQ
The company's return on assets rose by 48% YoY and by 40% QoQ
Dividends
What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GRI.
Financial health
How did GRI Bio financials performed over time
GRI's total assets has soared by 53% from the previous quarter and by 25% YoY
GRI's total liabilities is up by 44% year-on-year and by 29% since the previous quarter
GRI Bio's debt is 97% less than its equity
GRI's debt to equity has soared by 200% YoY but it is down by 40% from the previous quarter
The equity has soared by 69% from the previous quarter and by 17% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.